Stuart McCracken - Concepedia

Concepedia

Author

Stuart McCracken

Newcastle University

Also Known As

S McCracken, S R C McCracken, S R McCracken, S. McCracken, S. Mccracken, S. R. C. McCracken, S.R. Mccracken, S.R.C. McCracken, SRC McCracken, Stuart McCracken

89

Publications

1.7K

Citations

23

H-Index

44

Concepts

All Affiliations

Newcastle University Sunderland Royal Hospital University Hospital Southampton NHS Foundation Trust Imperial College London Imperial College Healthcare NHS Trust

SM

About

Stuart McCracken is an author at Newcastle University specializing in medicine, urology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	16	886
2	Cell Biology	7	7	547
3	Natural Sciences	3	3	248
4	Endocrinology	2	2	191
5	Health Sciences	1	1	19

Stuart McCracken

×

31

Publications

1.7K

Citations

23

H-Index

	Year	Citations
Prespecified dose-response analysis for A Very Early Rehabilitation Trial (AVERT) Julie Bernhardt, Leonid Churilov, Fiona Ellery, Neurology	2016	210
Early-Medium-Term Outcomes of Primary Focal Cryotherapy to Treat Nonmetastatic Clinically Significant Prostate Cancer from a Prospective Multicentre Registry Taimur T. Shah, Max Peters, David Eldred‐Evans, European Urology Surgical OncologyUrologyProspective Multicentre RegistryGenitourinary CancerMedicine	2019	138
Regulation of the androgen receptor by SET9-mediated methylation Luke Gaughan, Jacqueline Stockley, Nan Wang, Nucleic Acids Research Histone ModificationsAndrogen ReceptorEpigenetic ChangeGeneticsMolecular Biology	2010	121
Evaluation of the fibroblast growth factor system as a potential target for therapy in human prostate cancer Bharat Gowardhan, D. A. Douglas, Marie E. Mathers, British Journal of Cancer	2005	103
ERK5 signalling in prostate cancer promotes an invasive phenotype Alison Ramsay, Stuart McCracken, Madiha Emran Soofi, British Journal of Cancer	2011	89
Human PIRH2 Enhances Androgen Receptor Signaling through Inhibition of Histone Deacetylase 1 and Is Overexpressed in Prostate Cancer Ian R. Logan, Luke Gaughan, Stuart McCracken, Molecular and Cellular Biology Androgen ReceptorTranscriptional RegulationUrologySignal TransductionSignaling Pathway	2006	88
Aberrant expression of extracellular signal-regulated kinase 5 in human prostate cancer Stuart McCracken, A Ramsay, Rakesh Heer, Oncogene UrologySignaling PathwayMedicineAberrant ExpressionReceptor Tyrosine Kinase	2007	87
FUS/TLS Is a Novel Mediator of Androgen-Dependent Cell-Cycle Progression and Prostate Cancer Growth Greg N. Brooke, Rachel L. Culley, D. Alwyn Dart, Cancer Research Novel MediatorAndrogen ReceptorAndrogen-dependent Cell-cycle ProgressionCancer BiologyTumor Biology	2010	78
Huntingtin interacting protein 1 modulates the transcriptional activity of nuclear hormone receptors Ian G. Mills, Luke Gaughan, Craig Robson, The Journal of Cell Biology Androgen ReceptorActivated ReceptorsMolecular BiologyNuclear Hormone ReceptorsTranscriptional Regulation	2005	70
Focal therapy compared to radical prostatectomy for non-metastatic prostate cancer: a propensity score-matched study Taimur T. Shah, Deepika Reddy, Max Peters, Prostate Cancer and Prostatic Diseases UrologySurgical OncologyGenitourinary CancerMedicineFocal Therapy	2021	58

Page 1